加齢黄斑変性症は、50歳以上の人の視力低下の最も一般的な原因となっています。加齢黄斑変性症は、黄斑の機能が低下し、中心視力が低下する病気です。加齢、喫煙、日光、遺伝などが主な原因です。症状としては、死角ができたり、視界がぼやけたりします。この疾患は、光線力学療法、放射線療法、および抗血管新生薬などの薬物療法によって治療することができます。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Age Related Macular Degeneration - Overview
Age Related Macular Degeneration - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Age Related Macular Degeneration - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Age Related Macular Degeneration - Companies Involved in Therapeutics Development
Age Related Macular Degeneration - Drug Profiles
Age Related Macular Degeneration - Dormant Projects
Age Related Macular Degeneration - Discontinued Products
Age Related Macular Degeneration - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Age Related Macular Degeneration, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Target, 2022 (Contd..2)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Age Related Macular Degeneration - Dormant Projects, 2022
Age Related Macular Degeneration - Discontinued Products, 2022
List of Figures
Number of Products under Development for Age Related Macular Degeneration, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
